That’s now out – and the answer is still no. The cost-effectiveness agency for England and Wales says it can’t recommend routine NHS use of Aimovig (erenumab) for people suffering at least ...

Aimovig costs $575 per dose before insurance, but Amgen helps some patients, whose private health plans don’t cover the drug, get it at no cost for up to a year. —Jamie Ducharme ...

A copay assistance card is available for some through Aimovig’s manufacturer to help offset copay costs. Insurers may authorize coverage for Aimovig only after you’ve tried several less ...

People suffering from severe migraines in Scotland will be able to get treatment with Amgen and Novartis’ Aimovig if they fail other therapies, according to the country’s cost-effectiveness ...